One-point probability distribution function from spherical collapse: Early Dark Energy (EDE) vs. $Λ$CDM
Abstract
We compute the one-point PDF of an initially Gaussian dark matter density field using spherical collapse (SC). We compare the results to other forms available in the literature and also compare the PDFs in the $Λ$CDM model with an early dark energy (EDE) model. We find that the skewed log-normal distribution provides the best fit to the non-linear PDF from SC for both cosmologies, from $a=0.1$ to 1 and for scales characterized by the comoving width of the Gaussian: $σ_G = 0.5, 1, 2$. To elucidate the effect of cosmology, we examine the linear and non-linear growth rates through test cases. For overdensities, when the two models have the same initial density contrast, the differences due to cosmology are amplified in the non-linear regime, whereas, if the two models have the same linear density contrast today, then the differences in cosmology are damped in the non-linear regime. This behaviour is in contrast with voids, where the non-linear growth becomes `self-regulatory' and is less sensitive to cosmology and initial conditions. To compare the PDFs, we examine the difference of the PDFs and evolution of the width of the PDF. The trends with scale and redshift are as expected. A tertiary aim of this paper was to check if the fitting form for the non-linear density-velocity divergence relation, derived for constant equation of state ($w$) models by Nadkarni-Ghosh holds for the EDE model. We find that it does with an accuracy of 4\%, thus increasing its range of validity.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.